BOUNDLESS BIO INC (BOLD:NASDAQ)
$1.46 -0.01 (-0.6803%)
Analysed BOUNDLESS BIO INC (BOLD:NASDAQ) News Sources
Boundless Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference
24-11-2025
yahoo.com
Boundless Bio Advances Novel Kinesin Degrader Program BBI-940 and Extends Cash Runway
20-01-2026
yahoo.com
We're Keeping An Eye On Boundless Bio's (NASDAQ:BOLD) Cash Burn Rate
31-01-2026
yahoo.com
Boundless Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
05-02-2026
yahoo.com
Boundless Bio, Inc. (BOLD) Upgraded to Buy: Here's Why
13-02-2026
yahoo.com
Boundless Bio to Participate in the Leerink Global Healthcare Conference
04-03-2026
yahoo.com
Boundless Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
09-03-2026
yahoo.com
Boundless Bio Announces Upcoming Presentation of Oral Kinesin Degrader Program at the American Association for Cancer Research Annual Meeting 2026
17-03-2026
yahoo.com
Boundless Bio Presents Preclinical Breast Cancer Data from its Oral Kinesin Degrader Program at 2026 AACR Annual Meeting
17-04-2026
yahoo.com
Boundless Bio Reports First Quarter 2026 Financial Results and Business Highlights
08-05-2026
yahoo.com
What is the current price of BOUNDLESS BIO INC (BOLD:NASDAQ)?
The current price of BOUNDLESS BIO INC (BOLD:NASDAQ) is $1.46.
BOUNDLESS BIO INC (BOLD:NASDAQ) absolute price change since previous trading day?
The absolute price change of BOUNDLESS BIO INC (BOLD:NASDAQ) since the previous trading day is $-0.01.
BOUNDLESS BIO INC (BOLD:NASDAQ) percentage price change since previous trading day?
The percentage price change of BOUNDLESS BIO INC (BOLD:NASDAQ) since the previous trading day is -0.6803%.
What is the most recent average sentiment score for BOUNDLESS BIO INC (BOLD:NASDAQ)?
The most recent average sentiment score for BOUNDLESS BIO INC (BOLD:NASDAQ) is 89 out of 100.
What is the most recent average sentiment for BOUNDLESS BIO INC (BOLD:NASDAQ)?
The most recent sentiment for BOUNDLESS BIO INC (BOLD:NASDAQ) is .
SEC-8K** Filing Available For BOUNDLESS BIO INC (BOLD:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.